Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,307 | -7,873 | -5,767 | -2,864 | -11,623 |
| Depreciation Amortization | 199 | 151 | 103 | 52 | 240 |
| Accounts receivable | 85 | -307 | -495 | N/A | N/A |
| Other Working Capital | 1,792 | 289 | -510 | 643 | 1,687 |
| Other Operating Activity | 1,256 | 1,505 | 1,536 | 538 | 603 |
| Operating Cash Flow | $-6,975 | $-6,235 | $-5,133 | $-1,631 | $-9,093 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | 12 |
| Investing Cash Flow | $N/A | $0 | $0 | $N/A | $12 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 582 | -199 | -199 | 900 | N/A |
| Debt Issued | 450 | 450 | 450 | N/A | N/A |
| Common Stock Issued | 5,848 | 5,849 | 5,536 | 2,186 | 7,967 |
| Financing Cash Flow | $6,880 | $6,100 | $5,787 | $3,086 | $7,967 |
| Beginning Cash Position | 371 | 371 | 371 | 371 | 1,485 |
| End Cash Position | 276 | 236 | 1,025 | 1,826 | 371 |
| Net Cash Flow | $-95 | $-135 | $654 | $1,455 | $-1,114 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,975 | -6,235 | -5,133 | -1,631 | -9,093 |
| Capital Expenditure | N/A | N/A | N/A | N/A | 12 |
| Free Cash Flow | -6,975 | -6,235 | -5,133 | -1,631 | -9,081 |